1. Home
  2. QURE vs LAW Comparison

QURE vs LAW Comparison

Compare QURE & LAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • LAW
  • Stock Information
  • Founded
  • QURE 1998
  • LAW 2013
  • Country
  • QURE Netherlands
  • LAW United States
  • Employees
  • QURE N/A
  • LAW N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • LAW Computer Software: Prepackaged Software
  • Sector
  • QURE Health Care
  • LAW Technology
  • Exchange
  • QURE Nasdaq
  • LAW Nasdaq
  • Market Cap
  • QURE 432.6M
  • LAW 356.9M
  • IPO Year
  • QURE 2007
  • LAW 2021
  • Fundamental
  • Price
  • QURE $6.65
  • LAW $5.95
  • Analyst Decision
  • QURE Buy
  • LAW Hold
  • Analyst Count
  • QURE 6
  • LAW 4
  • Target Price
  • QURE $19.50
  • LAW $7.38
  • AVG Volume (30 Days)
  • QURE 846.7K
  • LAW 80.7K
  • Earning Date
  • QURE 11-05-2024
  • LAW 11-07-2024
  • Dividend Yield
  • QURE N/A
  • LAW N/A
  • EPS Growth
  • QURE N/A
  • LAW N/A
  • EPS
  • QURE N/A
  • LAW N/A
  • Revenue
  • QURE $27,707,000.00
  • LAW $142,261,000.00
  • Revenue This Year
  • QURE $187.60
  • LAW $6.13
  • Revenue Next Year
  • QURE $51.90
  • LAW $6.26
  • P/E Ratio
  • QURE N/A
  • LAW N/A
  • Revenue Growth
  • QURE N/A
  • LAW 5.84
  • 52 Week Low
  • QURE $3.73
  • LAW $4.71
  • 52 Week High
  • QURE $11.35
  • LAW $8.80
  • Technical
  • Relative Strength Index (RSI)
  • QURE 63.87
  • LAW 59.74
  • Support Level
  • QURE $6.01
  • LAW $5.87
  • Resistance Level
  • QURE $6.55
  • LAW $6.03
  • Average True Range (ATR)
  • QURE 0.54
  • LAW 0.13
  • MACD
  • QURE 0.18
  • LAW -0.01
  • Stochastic Oscillator
  • QURE 91.67
  • LAW 71.43

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

Share on Social Networks: